Cardiomyocyte marker expression in a human lymphocyte cell line using mouse cardiomyocyte extract

Human Cell

Volumn 24, Issue 1, 2011, Pages 35-42

  Vojdani, Zahra ^a,b   Tavakolinejad, Sima ^a   Talaei Khozani, Tahereh ^a   Esmaeilpour, Tahereh ^a   Rasooli, Manuchehr ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5 Aza 2 deoxycytidine; Cardiomyocyte; Cell free extract; Lymphocyte; Trichostatin A

Indexed keywords

ALPHA ACTININ; CELL EXTRACT; CELL MARKER; MYOSIN HEAVY CHAIN; TROPONIN T;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL SHAPE; CELL STRUCTURE; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; HEART MUSCLE CELL; LYMPHOID CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ACTINS; ANIMALS; AZACITIDINE; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL EXTRACTS; CELL MEMBRANE PERMEABILITY; CELL TRANSDIFFERENTIATION; FLOW CYTOMETRY; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; MICE; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; TROPONIN T;

EID: 79952907512     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1007/s13577-011-0009-0     Document Type: Article

References (37)

1. Shunsuke O, Hajime O, Soichiro K, Noritoshi N. Mesenchymal stem cells for the treatment of heart failure. Int J Hematol. 2007; 86: 17-21.
2. Nagaya N, Kangawa K, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation. 2005; 112: 1128-35.
3. Davies B, Elwood NJ, Li S, et al. Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training. Ann Thorac Surg. 2010; 89: 585-93.
4. He Q, Trindade PT, Stumm M, et al. Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression. J Cell Mol Med. 2009; 13: 188-201.
5. Chen YR, Li Y, Chen L, Yang XC, Su PX, Cai J. The infarcted cardiac microenvironment cannot selectively promote embryonic stem cell differentiation into cardiomyocytes. Cardiovasc Pathol. 2010; 123: 979-83.
6. Catalucci D, Bang ML, Condorelli G. Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? Br J Pharmacol. 2008; 153: 625-6.
7. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105: 93-8.
8. Xu W, Zhang X, Qian H, et al. Mesenchymal stem cells from adult bone marrow differentiation into a cardiomyocyte phenotype in vitro. Exp Biol Med. 2004; 229: 623-31.
9. Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg. 2007; 6: 593-7.
10. Labovsky V, Hofer EL, Feldman L, et al. Cardiomyogenic differentiation of human bone marrow mesenchymal cells: role of cardiac extract from neonatal rat cardiomyocytes. Differentiation. 2009; 79: 93-101.
11. Gaustad KG, Boquest AC, Andersone BE, Gerdes AM, Collas P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun. 2004; 314: 420-7.
12. Badorff C, Brandes RP, Popp R, et al. Transdifferentiation of blood derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation. 2003; 107: 1024-32.
13. Rajasingh J, Lambers E, Hamada H, et al. Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res. 2008; 102: 107-17.
14. Neri T, Monti M, Rebuzzini P, et al. Mouse fibroblasts are reprogrammed to Oct-4 and Rex-1 gene expression and alkaline phosphatase activity by embryonic stem cell extracts. Cloning Stem Cells. 2007; 9: 394-406.
15. Choi KS, Shin JS, Lee JJ, Kim YS, Kim SB, Kim CW. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun. 2005; 330: 1299-305.
16. MacDonald JL, Roskams AJ. Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation. Prog Neurobiol. 2009; 88: 170-83.
17. Tada T. Toti-pluripotential stem cells and epigenetic modifications. Neurodegener Dis. 2006; 3: 32-7.
18. De Boer J, Licht R, Bongers M, van der Klundert T, Arends R, van Blitterswijk C. Inhibition of histone acetylation as a tool in bone tissue engineering. Tissue Eng. 2006; 12: 2927-37.
19. Kiziltepe T, Hideshima T, Catley L, et al. 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. Mol Cancer Ther. 2007; 6: 1718-27.
20. Shenoi BV. In vitro lymphocyte-to-granulocyte transdifferentiation induced by chemicals. Curr Sci. 2004; 87: 491-4.
21. Szilvassy SJ. The biology of hematopoietic stem cells. Arch Med Res. 2003; 34: 446-60.
22. Wu D, Hamilton B, Martin C, Gao Y, Ye M, Yao S. Generation of induced pluripotent stem cells by reprogramming human fibroblasts with the stemgent human TF lentivirus set. J Vis Exp. 2009; 34: pii 1553. doi: 10. 3791/1553.
23. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76.
24. Aasen T, Belmonte JC. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc. 2010; 5: 371-82.
25. Håkelien AM, Gaustad KG, Collas P. Transient alteration of cell fate using a nuclear and cytoplasmic extract of an insulinoma cell line. Biochem Biophys Res Commun. 2004; 9: 834-41.
26. Xu YN, Guan N, Wang ZD, et al. ES cell extract-induced expression of pluripotent factors in somatic cells. Anat Rec (Hoboken). 2009; 292(8): 1229-34.
27. Gai H, Leung EL, Costantino PD, et al. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol Int. 2009; 33: 1184-93.
28. Zhao J, Hao Y, Ross JW, et al. Histone deacetylase inhibitors improve in vitro and in vivo developmental competence of somatic cell nuclear transfer porcine embryos. Cloning Stem Cells. 2010; 12: 75-83.
29. Cervera RP, Martí-Gutiérrez N, Escorihuela E, Moreno R, Stojkovic M. Trichostatin A affects histone acetylation and gene expression in porcine somatic cell nucleus transfer embryos. Theriogenology. 2009; 72: 1097-110.
30. Zhang XM, Li QM, Su DJ, et al. RA induces the neural-like cells generated from epigenetic modified NIH/3T3 cells. Mol Biol Rep. 2010; 37: 1197-202.
31. Kablar B, Krastel K, Tajbakhsh S, Rudnicki MA. Myf5 and MyoD activation define independent myogenic compartments during embryonic development. Dev Biol. 2003; 258: 307-18.
32. Kaminski R, Kozar K, Niderla J, et al. Demethylating agent 5-aza-2′-deoxycytidine enhances expression of TNFRI and promotes TNF-mediated apoptosis in vitro and in vivo. Oncol Rep. 2004; 12(3): 509-16.
33. Sigalotti L, Altomonte M, Colizzi F, et al. 5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach? Blood. 2003; 101: 4644-6.
34. Wernig G, Janzen V, Schäfer R, et al. The vast majority of bone-marrow-derived cells integrated into mdx muscle fibers are silent despite long-term engraftment. Proc Natl Acad Sci USA. 2005; 102: 11852-7.
35. Champion C, Guianvarc'h D, Sénamaud-Beaufort C, et al. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine. PLoS One. 2010; 5: e12388.
36. Iwatani M, Ikegami K, Kremenska Y, et al. Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body. Stem Cells. 2006; 24: 2549-56.
37. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001; 108: 407-14.